Valuation Eurofins Scientific SE

Stocks

Real-time Euronext Paris 19:35:03 09/09/2026 +04			5-day change	1st Jan Change
70.94 ^EUR	-0.37%		-2.53%	+13.69%

09-08	Eurofins Scientific Downgraded by Morgan Stanley
08-24	Wall Street's Three-Way Stress Test

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	20,893	12,900	11,336	9,273	11,036	12,360	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	12%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	14,677	15,726	15,394	15,157
Change	-	-31.96%	-10.79%	-12.62%	19.63%	7.15%	-2.11%	-1.54%
P/E	27.8x	22.2x	45.4x	26.9x	28x	23.7x	18.8x	15.8x
PBR	4.49x	2.7x	2.24x	1.73x	2.56x	2.64x	2.4x	2.22x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.7x	0.7x	0.8x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.63x	1.55x	1.45x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	2.01x	2.07x	1.92x	1.78x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	8.94x	8.99x	8.12x	7.34x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	13.6x	13.9x	12.3x	10.9x
EV / FCF	22.8x	23.2x	29.6x	15.3x	16.7x	18.1x	16.2x	14.6x
FCF Yield	4.39%	4.3%	3.38%	6.53%	5.97%	5.54%	6.17%	6.87%
Dividend per Share ²	1	1	0.5	0.5	0.72	0.8022	0.908	0.9603
Rate of return	0.92%	1.49%	0.85%	1.01%	1.15%	1.13%	1.28%	1.35%
EPS ²	3.91	3.02	1.3	1.83	2.23	2.999	3.796	4.504
Distribution rate	25.6%	33.1%	38.5%	27.3%	32.3%	26.7%	23.9%	21.3%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,583	7,998	8,529
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,750	1,895	2,064
EBIT ¹	1,473	1,037	842	1,017	1,079	1,129	1,250	1,387
Net income ¹	783	606	310	406	475	530.9	659.7	817.4
Net Debt ¹	2,239	2,839	2,705	2,996	3,641	3,366	3,034	2,796
Reference price ²	108.80	67.06	58.98	49.31	62.40	71.20	71.20	71.20
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	173,599	-	-
Announcement Date	22/02/22	01/03/23	27/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EUROFINS SCIENTIFIC SE	23.74x	2.07x	8.99x	1.13%	14.38B
LONZA GROUP AG	32.49x	5.84x	17.49x	1%	48.01B
REVOLUTION MEDICINES, INC.	-21.22x	242.27x	-22.87x	-.--%	44.44B
IQVIA HOLDINGS INC.	33.38x	3.24x	14x	-.--%	42.67B
BEONE MEDICINES AG	46.04x	5.32x	29.1x	-.--%	39.96B
CELLTRION, INC.	27.78x	8.36x	21.2x	0.41%	32.75B
MEDPACE HOLDINGS, INC.	33.6x	5.5x	25x	-.--%	16.49B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	75.11x	3.97x	15.39x	-.--%	13.4B
ICON PUBLIC LIMITED COMPANY	26.88x	1.79x	10.98x	-.--%	12.22B
Average	30.87x	30.93x	13.25x	0.28%	29.37B
Weighted average by Cap.	26.56x	44.89x	11.95x	0.29%